Posts Tagged ‘Moderna’
Moderna begins study of vaccine in children, 6 mos-12 yrs
Enrolling 6,750 healthy pediatric participants less than 12 years of age in the U.S. and Canada Moderna Inc., a biotechnology company pioneering messenger RNA(mRNA) therapeutics and vaccines, today announced that the first participants have been dosed in the Phase 2/3 study, called the KidCOVE study, ofmRNA-1273, the Company’s vaccine candidate against COVID-19, in children ages…
Read MoreYour Coronavirus Update – Today, Dec. 21, 2020
Photo: Good idea gone very wrong. Pop-Up sites seemed like a good idea, but resulted in traffic jams, sites late in opening and closing early – and this very disturbing scene at the Warwick Mall – where hundreds of people lined up indoors for tests, walking around the mall for 15 minutes, then returning for…
Read MoreWho is next for the vaccine? CDC announces priorities
Next in line for the vaccines? Those over 75 and frontline essential workers. This comes as the Moderna vaccine rolled out of its Mississippi. Those groups follow frontline health care workers and nursing home residents, who have already begun receiving the limited supplies of vaccines available. The CDC’s Advisory Committee on Immunization Practices voted Sunday…
Read MoreFDA Says “Go!” to Moderna COVID19 Vaccine
Friday night, the U.S. Food and Drug Administration issued an emergency use authorization for the second vaccine for the prevention of COVID-19. The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older. From the FDA: “With the availability of two…
Read MoreModerna vaccine one step closer. At FDA. May ship this weekend. US reserves 100 million more doses.
The U.S. Food and Drug Administration released a 54-page document outlining Moderna’s (MRNA) request for an emergency use authorization (EUA) Tuesday, bringing the biotech one step closer to the finish line. Though it is widely anticipated that an EUA is issued by the weekend, based on the precedent set by Pfizer (PFE) and BioNTech (BNTX)…
Read MoreModerna applies today to FDA for COVID-19 Vaccine emergency use authorization
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization Primary efficacy analysis of the Phase 3 COVE study of mRNA-1273 involving 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe Vaccine efficacy against COVID-19 was…
Read MoreDolly Parton COVID Fund at Moderna – “Vaccine, vaccine, vaccine… “
Dolly Parton last night spoke of her joy at helping to fund the production of a promising new coronavirus vaccine. Parton, back in April, donated $1 Million to the Vanderbilt University Medical Center, that was partnering with Cambridge, MA based Moderna on a COVID-19 vaccine. Parton said: “I am a very proud girl today that…
Read MoreModerna, 2nd Operation Warp Speed partner, announces Vaccine #2 – 95% effective
On Twitter: We just announced that mRNA-1273, our COVID-19 vaccine candidate, has met its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study. Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the independent, NIH-appointed…
Read More